Skip to main content
See every side of every news story
Published loading...Updated

Optimising a behavioural intervention to support endocrine therapy adherence for women with breast cancer: Protocol for the ROSETA optimisation randomised controlled trial

Background Adjuvant endocrine therapy (AET) reduces breast cancer recurrence and mortality. However, up to three quarters of women with breast cancer do not take AET as prescribed. Existing interventions to support adherence have shown limited effectiveness and often do...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

researchsquare.com broke the news in on Wednesday, September 17, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal